Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
NEW YORK, Aug. 28, 2024 ( GLOBE NEWSWIRE ) -- Intra-Cellular Therapies, Inc. ( Nasdaq: ITCI ) , a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system ( CNS ) disorders, today announced that Sharon Mates, Ph.D., Chief Executive ...
| Ticker |
Sentiment |
Impact |
|
MS
|
Neutral
|
18 %
|
|
ITCI
|
Neutral
|
51 %
|
